Contributions of NanI sialidase to Caco-2 cell adherence by Clostridium perfringens type A and C strains causing human intestinal disease

Infection and Immunity

Volumn 82, Issue 11, 2014, Pages 4620-4630

  Li, Jihong ^a   McClane, Bruce A ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENTEROTOXIN; NANI SIALIDASE; SIALIDASE; SIALIDASE INHIBITOR; UNCLASSIFIED DRUG;

ANTIBIOTIC ASSOCIATED DIARRHEA; ARTICLE; BACTERIUM ADHERENCE; CACO 2 CELL LINE; CELL ADHESION; CLOSTRIDIUM; CLOSTRIDIUM PERFRINGENS TYPE A; CLOSTRIDIUM PERFRINGENS TYPE C; CONTROLLED STUDY; DNA ISOLATION; ELECTROPORATION; ENTEROPATHY; ENZYME ACTIVITY; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; SOUTHERN BLOTTING; SPOROGENESIS; WESTERN BLOTTING; CLASSIFICATION; CLOSTRIDIUM INFECTION; CLOSTRIDIUM PERFRINGENS; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MICROBIOLOGY; MUTATION; PHYSIOLOGY;

BACTERIAL ADHESION; CACO-2 CELLS; CLOSTRIDIUM INFECTIONS; CLOSTRIDIUM PERFRINGENS; GENE EXPRESSION REGULATION, BACTERIAL; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; INTESTINAL DISEASES; MUTATION; NEURAMINIDASE;

EID: 84907958782     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.02322-14     Document Type: Article

References (43)

1. McClane BA, Robertson SL, Li J. 2013. Clostridium perfringens, p 465-489. In Doyle MP, Buchanan RL (ed), Food microbiology: fundamentals and frontiers, 4th ed. ASM Press, Washington, DC.
2. McClane BA, Uzal FA, Miyakawa MF, Lyerly D, Wilkins TD. 2006. The enterotoxic clostridia, p 688-752. In Dworkin M, Falkow S, Rosenburg E, Schleifer H, Stackebrandt E (ed), The prokaryotes, 3rd ed. Springer, New York, NY.
3. Hatheway C. 1990. Toxigenic clostridia. Clin. Microbiol. Rev. 3:66-76.
4. McDonel JL. 1986. Toxins of Clostridium perfringens types A, B, C, D, and E, p 477-517. In Dorner F, Drews H (ed), Pharmacology of bacterial toxins. Pergamon Press, Oxford, United Kingdom.
5. Petit L, Gilbert M, Popoff M. 1999. Clostridium perfringens: toxinotype and genotype. Trends Microbiol. 7:104-110. http://dx.doi.org/10.1016/S0966-842X(98)01430-9.
6. CDC. 2011. Clostridium perfringens. http://www.cdc.gov/foodsafety/clostridium-perfingens.html.
7. Scallan E, Hoekstra RM, Angulo FJ, Tauxe RV, Widdowson M, Roy S, Jones JL, Griffin PM. 2011. Foodborne illness acquired in the United States-major pathogens. Emerg. Infect. Dis. 17:7-15. http://dx.doi.org/10.3201/eid1701.09-1101p1.
8. Carman RJ. 1997. Clostridium perfringens in spontaneous and antibiotic-associated diarrhoea of man and other animals. Rev. Med. Microbiol. 8(Suppl 1):S43-S45. http://dx.doi.org/10.1097/00013542-199712001-00023.
9. Collie RE, McClane BA. 1998. Evidence that the enterotoxin gene can be episomal in Clostridium perfringens isolates associated with nonfoodborne human gastrointestinal diseases. J. Clin. Microbiol. 36:30-36.
10. Cornillot E, Saint-Joanis B, Daube G, Katayama S, Granum PE, Carnard B, Cole ST. 1995. The enterotoxin gene (cpe) of Clostridium perfringens can be chromosomal or plasmid-borne. Mol. Microbiol. 15:639-647.
11. Li J, McClane BA. 2008. A novel small acid soluble protein variant is important for spore resistance of most Clostridium perfringens food poisoning isolates. PLoS Pathog. 4:e1000056. http://dx.doi.org/10.1371/journal.ppat.1000056.
12. Deguchi A, Miyamoto K, Kuwahara T, Kaneko I, Li J, McClane BA, Akimoto S. 2009. Genetic characterization of type A entertoxigenic Clostridium perfringens strains. PLoS One 4:e5598. http://dx.doi.org/10.1371/journal.pone.0005598.
13. Johnson S, Gerding DN. 1997. Enterotoxemic infections, p 117-140. In Rood JI, McClane BA, Songer JG, Titball RW (ed), The clostridia: molecular genetics and pathogenesis. Academic Press, London, United Kingdom.
14. Gurjar A, Li J, McClane BA. 2010. Characterization of toxin plasmids in Clostridium perfringens type C isolates. Infect. Immun. 78:4860-4869. http://dx.doi.org/10.1128/IAI.00715-10.
15. Fisher DJ, Fernandez-Miyakawa ME, Sayeed S, Poon R, Adams V, Rood JI, Uzal FA, McClane BA. 2006. Dissecting the contributions of Clostridium perfringens type C toxins to lethality in the mouse intravenous injection model. Infect. Immun. 74:5200-5210. http://dx.doi.org/10.1128/IAI.00534-06.
16. Ma M, Li J, McClane BA. 2012. Genotypic and phenotypic characterization of Clostridium perfringens isolates from Darmbrand cases in post-World War II Germany. Infect. Immun. 80:4354-4363. http://dx.doi.org/10.1128/IAI.00818-12.
17. Lawrence GW. 1997. The pathogenesis of enteritis necroticans, p 198-207. In Rood JI, McClane BA, Songer JG, Titball RW (ed), The clostridia: molecular genetics and pathogenesis. Academic Press, London, United Kingdom.
18. Matsuda T, Okada Y, Inagi E, Tanabe Y, Shimizu Y, Nagashima K, Sakurai J, Nagahama M, Tanaka S. 2007. Enteritis necroticans 'Pig-Bel' in a Japanese diabetic adult. Pathol. Int. 57:622-626. http://dx.doi.org/10.1111/j.1440-1827.2007.02149.x.
19. Petrillo TM, Beck-Sague CM, Songer JG, Abramowsky C, Fortenberry JD, Meacham L, Dean AG, Lee H, Bueschel DM, Nesheim SR. 2000. Enteritis necroticans (Pig-Bel) in a diabetic child. N. Engl. J. Med. 342:1250-1253. http://dx.doi.org/10.1056/NEJM200004273421704.
20. Krachler AM, Orth K. 2013. Targeting the bacteria-host interface: strategies in anti-adhesion therapy. Virulence 4:284-294. http://dx.doi.org/10.4161/viru.24606.
21. Li J, Sayeed S, Robertson S, Chen J, McClane BA. 2011. Sialidases affect the host cell adherence and epsilon toxin-induced cytotoxicity of Clostridium perfringens typeDstrain CN3718. PLoS Pathog. 7:e1002429. http://dx.doi.org/10.1371/journal.ppat.1002429.
22. Li J, Ma M, Sarker MR, McClane BA. 2013. CodY is a global regulator of virulence-associated properties for Clostridium perfringens type D strain CN3718. mBio 4:e00770-13. http://dx.doi.org/10.1128/mBio.00770-13.
23. Popoff MR. 2011. Epsilon toxin: a fascinating pore-forming toxin. FEBS J. 278:4602-4615. http://dx.doi.org/10.1111/j.1742-4658.2011.08145.x.
24. Sparks SG, Carman RJ, Sarker MR, McClane BA. 2001. Genotyping of enterotoxigenic Clostridium perfringens isolates associated with gastrointestinal disease in North America. J. Clin. Microbiol. 39:883-888. http://dx.doi.org/10.1128/JCM.39.3.883-888.2001.
25. Bos J, Smithee L, McClane B, Distefano RF, Uzal F, Songer JG, Mallonee S, Crutcher JM. 2005. Fatal necrotizing colitis following a foodborne outbreak of enterotoxigenic Clostridium perfringens type A infection. Clin. Infect. Dis. 40:e78-e83. http://dx.doi.org/10.1086/429829.
26. Carman RJ, Sayeed S, Li J, Genheimer CW, Hiltonsmith MF, Wilkins TD, McClane BA. 2008. Clostridium perfringens toxin genotypes in the feces of healthy North Americans. Anaerobe 14:102-108. http://dx.doi.org/10.1016/j.anaerobe.2008.01.003.
27. Ma M, Gurjar A, Theoret JR, Garcia JP, Beingesser J, Freedman JC, Fisher DJ, McClane BA, Uzal FA. 2014. Synergistic effects of Clostridium perfringens enterotoxin and beta toxin in rabbit small intestinal loops. Infect. Immun. 82:2958-2970. http://dx.doi.org/10.1128/IAI.01848-14.
28. Li J, McClane BA. 2014. The sialidases of Clostridium perfringens type D strain CN3718 differ in their properties and sensitivities to inhibitors. Appl. Environ. Microbiol. 80:1701-1709. http://dx.doi.org/10.1128/AEM.03440-13.
29. Li J, Miyamoto K, McClane BA. 2007. Comparison of virulence plasmids among Clostridium perfringens type E isolates. Infect. Immun. 75:1811-1819. http://dx.doi.org/10.1128/IAI.01981-06.
30. Chen Y, McClane BA, Fisher DJ, Rood JI, Gupta P. 2005. Construction of an alpha toxin gene knockout mutant of Clostridium perfringens type A by use of a mobile group II intron. Appl. Environ. Microbiol. 71:7542-7547. http://dx.doi.org/10.1128/AEM.71.11.7542-7547.2005.
31. Li J, Chen J, Vidal JE, McClane BA. 2011. The Agr-like quorum-sensing system regulates sporulation and production of enterotoxin and beta2 toxin by Clostridium perfringens type A non-food-borne human gastrointestinal disease strain F5603. Infect. Immun. 79:2451-2459. http://dx.doi.org/10.1128/IAI.00169-11.
32. Vidal JE, Ohtani K, Shimizu T, McClane BA. 2009. Contact with enterocyte-like Caco-2 cells induces rapid upregulation of toxin production by Clostridium perfringens type C isolates. Cell. Microbiol. 11:1306-1328. http://dx.doi.org/10.1111/j.1462-5822.2009.01332.x.
33. Kondo T, Johnson SA, Yoder MC, Romand R, Hashino E. 2005. Sonic hedgehog and retinoic acid synergistically promote sensory fate specification from bone marrow-derived pluripotent stem cells. Proc. Natl. Acad. Sci. U. S. A. 102:4789-4794. http://dx.doi.org/10.1073/pnas.0408239102.
34. Li J, McClane BA. 2006. Further comparison of temperature effects on growth and survival of Clostridium perfringens type A isolates carrying a chromosomal or plasmid-borne enterotoxin gene. Appl. Environ. Microbiol. 72:4561-4568. http://dx.doi.org/10.1128/AEM.00177-06.
35. Chiarezza M, Lyras D, Pidot SJ, Flore-Diaz M, Awad MM, Kennedy CL, Cordner LM, Phumoonna T, Poon R, Hughes ML, Emmins JJ, Alape-Giron A, Rood JI. 2009. The NanI and NanJ sialidases of Clostridium perfringens are not essential for virulence. Infect. Immun. 77:4421-4428. http://dx.doi.org/10.1128/IAI.00548-09.
36. Mirouze N, Prepiak P, Dubnau D. 2011. Fluctuations in spo0A transcrip-tion control rare developmental transitions in Bacillus subtilis. PLoS Genet. 7:e1002048. http://dx.doi.org/10.1371/journal.pgen.1002048.
37. Huang IH, Waters M, Grau RR, Sarker MR. 2004. Disruption of the gene (spo0A) encoding sporulation transcription factor blocks endospore formation and enterotoxin production in enterotoxigenic Clostridium perfringens type A. FEMS Microbiol. Lett. 233:233-240. http://dx.doi.org/10.1111/j.1574-6968.2004.tb09487.x.
38. Boraston AB, Ficko-Blean E, Healey M. 2007. Carbohydrate recognition by a large sialidase toxin from Clostridium perfringens. Biochemistry 46:11352-11360. http://dx.doi.org/10.1021/bi701317g.
39. Fraser AG, Collee JG. 1975. The production of neuraminidase by food poisoning strains of Clostridium welchii (C. perfringens). J. Med. Microbiol. 8:251-263. http://dx.doi.org/10.1099/00222615-8-2-251.
40. Li J, Paredes-Sabja D, Sarker MR, McClane BA. 2009. Further characterization of Clostridium perfringens small acid soluble protein-4 (Ssp4) properties and expression. PLoS One 4:e6249. http://dx.doi.org/10.1371/journal.pone.0006249.
41. Ley RE. 2014. Harnessing microbiota to kill a pathogen: the sweet tooth of Clostridium difficile. Nat. Med. 20:248-249. http://dx.doi.org/10.1038/nm.3494.
42. Siegel SJ, Roche AM, Weiser JN. 2014. Influenza promotes pneumococcal growth during coinfection by providing host sialylated substrates as a nutrient source. Cell Host Microbe 16:55-67. http://dx.doi.org/10.1016/j.chom.2014.06.005.
43. De Clercq E. 2006. Antiviral agents active against influenza A viruses. Nat. Rev. Drug Discov. 5:1015-1025. http://dx.doi.org/10.1038/nrd2175.